BloombergYour Daily Pharma Scoop: Crispr On Hold, AstraZeneca Stumbles Again, TherapeuticsMD Receives FDA ApprovalSeeking AlphaCrispr Therapeutics (NASDAQ:CRSP) is one of the three companies that specialises in CRISPR-Cas9 genome editing technique. All… Continue reading
New Immunotherapy Increases Brain Cancer Patient Survival TimeAJMC.com Managed Markets NetworkTocagen, a cancer-selective gene therapy company, is developing a new immunotherapy for patients with recurrent brain cancer called Toca 511 and Toca FC, refe… Continue reading
University of California |
Baby born in world’s first in utero stem cell transplant trial
University of California An in utero stem cell transplant for a critically ill second-trimester fetus has led to the birth of an apparently healthy infant. The newborn is the first patient enrolled in the world’s first clinical trial using stem cells transplanted prior to … |
University of California |
Baby born in world’s first in utero stem cell transplant trial
University of California An in utero stem cell transplant for a critically ill second-trimester fetus has led to the birth of an apparently healthy infant. The newborn is the first patient enrolled in the world’s first clinical trial using stem cells transplanted prior to … |
|
Synthetic ‘Tissues’ Build Themselves
UCSF News Services … Distinguished Professor in the Department of Cellular and Molecular Pharmacology at UCSF, director of the NIH-funded Center for Systems and Synthetic Biology, and co-director of the National Science Foundation–funded Center for Cellular Construction. |